Announcements Trials
Browse Landscape

Status

Completed 72Recruiting 26Active not recruiting 18Terminated 15Unknown 7Approved for marketing 2Withdrawn 1Not yet recruiting 1No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 19INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 155Thoracic 140Other solid neoplasm 120Breast 78Genitourinary 67Gynecologic 62Lymphoid 61Other hematologic neoplasm 47CNS 35Plasma cell 34Head & Neck 29Dermatologic 27Tumor-Agnostic 24Sarcoma 19Myeloid 12Endocrine 6Classical hematology 5Other neoplasm 2Other 1NET 1

Conditions

Neuroendocrine Tumors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × NET × Clear all
NCT05967481 2023-08-01

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Power Life Sciences Inc.

Not yet recruiting
500 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡